DAVID H. FRANKEL, M.D.; MICHAEL O. BLACKSTONE, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In his review of the clinical uses of cimetidine (1), Freston concludes that although "evidence that cimetidine is effective in controlling established bleeding is lacking . . . it seems reasonable to use combination therapy in preventing rebleeding . . . [especially] . . . if the bleeding is due to peptic ulcer disease." We believe, however, that the evidence supporting the combined use of antacids plus cimetidine to prevent rebleeding in peptic ulcer disease is also lacking or, at best, questionable.
Freston bases his conclusion on a multicenter study of 557 patients in whom the combination
FRANKEL DH, BLACKSTONE MO. Cimetidine and Antacids. Ann Intern Med. 1983;98:412–413. doi: https://doi.org/10.7326/0003-4819-98-3-412_2
Download citation file:
Published: Ann Intern Med. 1983;98(3):412-413.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use